Oxford Nanopore Technologies (LON:ONT – Free Report) had its price objective reduced by Berenberg Bank from GBX 282 ($3.64) ...

DNA sequencing specialist’s decision to list in London in 2021 was seen as a victory for the market at the time ...

After a serious stock market slump, the boss of this FTSE 250 biotech company has reportedly highlighted its takeover exposure. The post Down 83%! This FTSE 250 firm could now be a stock market ...

Oxford Nanopore Technologies plc (LON:ONT – Get Free Report) traded up 10% during mid-day trading on Saturday . The company traded as high as GBX 103.10 ($1.33) and last traded at GBX 102.20 ($1.32).

While currently waiting for parliamentary approval, once granted, Adeyoola will lead Innovate UK, the country’s primary ...

Oxford Nanopore Technologies announced its expanded collaboration with 10x Genomics, Inc. to enable seamless compatibility between their latest technologies, bringing more accurate, cost-effective and ...

RBC Capital analyst Charles Weston maintained a Buy rating on Oxford Nanopore Technologies PLC (ONT – Research Report) today and set a price ...

Building the world's largest biobank with data from global populations to accelerate biomarker and drug discovery and ...

Bio-Techne Corporation TECH recently announced Asuragen’s — a Bio-Techne brand —partnership with Oxford Nanopore Technologies to launch the AmplideX Nanopore Carrier Plus Kit. The research ...

LONDON - Oxford Nanopore Technologies plc, a company specializing in nanopore-based DNA and RNA sequencing technology, has disclosed a transaction involving Nick Keher, the Chief Financial Officer ...